Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase (Q36626064)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2004

Language	Label	Description	Also known as
English	Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase	scientific article published on August 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

M Deichmann

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B Kahle

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K Moser

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Wacker

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K Wüst

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

91

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

699-702

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

The role of C-reactive protein as a prognostic indicator in advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

The incidence of malignant melanoma in the United States: issues as we approach the 21st century

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Interleukin-6 and its relation to inflammation and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

30 September 2017

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

28 June 2018

Metabolic disturbance and sensitivity to endotoxin in patients with advanced cancer: relationship to lymphocyte reactivity, tumour necrosis factor (TNF) production and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

28 June 2018

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

28 June 2018

Interleukin-6 production by human melanoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

28 June 2018

Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100beta or melanoma inhibitory activity (MIA)?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

20 September 2018

Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364774

20 September 2018

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602043

21 January 2018

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602043

21 January 2018

The biology of interleukin-6

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15280926

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6602043

0 references

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36626064&oldid=2199113623"